Translational Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Brain Pathol. 2010 Nov;20(6):1096-105. doi: 10.1111/j.1750-3639.2010.00416.x. Epub 2010 Jul 13.
Tuberous sclerosis complex (TSC) is an often severe neurocutaneous syndrome. Cortical tubers are the predominant neuropathological finding in TSC, and their number and location has been shown to correlate roughly with the severity of neurologic features in TSC. Past studies have shown that genomic deletion events in TSC1 or TSC2 are very rare in tubers, and suggested the potential involvement of the MAPK pathway in their pathogenesis. We used deep sequencing to assess all coding exons of TSC1 and TSC2, and the activating mutation hot spots within KRAS in 46 tubers from TSC patients. Germline heterozygous mutations were identified in 81% of tubers. The same secondary mutation in TSC2 was identified in six tuber samples from one individual. Further study showed that this second hit mutation was widely distributed in the cortex from one cerebral hemisphere of this individual at frequencies up to 10%. No other secondary mutations were found in the other 40 tubers analyzed. These data indicate that small second hit mutations in any of these three genes are very rare in TSC tubers. However, in one TSC individual, a second hit TSC2 point mutation occurred early during brain development, and likely contributed to tuber formation.
结节性硬化症复合征(TSC)是一种常伴有严重神经皮肤综合征的疾病。皮质结节是 TSC 的主要神经病理学表现,其数量和位置与 TSC 患者神经功能的严重程度大致相关。既往研究表明 TSC1 或 TSC2 中的基因组缺失事件在结节中非常罕见,并提示 MAPK 通路可能参与其发病机制。我们使用深度测序技术评估了 46 个 TSC 患者结节中的 TSC1 和 TSC2 的所有编码外显子,以及 KRAS 中的激活突变热点。在 81%的结节中发现了胚系杂合突变。同一 TSC2 的继发突变在一个个体的六个结节样本中被鉴定出来。进一步的研究表明,这种二次打击突变在该个体大脑一个半球的皮质中分布广泛,频率高达 10%。在分析的另外 40 个结节中未发现其他继发突变。这些数据表明,在 TSC 结节中,这些三个基因中的任何一个发生小的二次打击突变都非常罕见。然而,在一个 TSC 个体中,TSC2 点突变在大脑发育早期发生,可能促成了结节的形成。